EPA Plus Statin Treatment Reduces Risk of Recurrent Stroke
Friday, January 30th, 2009Readers of the PUFA Newsletter may recall the JELIS trial conducted among hypercholesterolemic patients treated with statins to lower their low-density lipoprotein cholesterol. Half the participants received 1.8 g/day of eicosapentaenoic acid (EPA) with their statin medication. Five years later, patients taking both a statin and EPA incurred significantly fewer major coronary events, such as […]